Pharmaceutical Raw Materials and Excipients No Further a Mystery
“The current problem has uncovered some structural weaknesses inside the EU’s medicines provide chain along with a significant dependence on non-EU international locations for active pharmaceutical ingredients,” Kyriakides said. She proposed that provide chain concerns be resolved within an EU pharmaceutical approach envisioned to be launched